Recent Finacing
Recent Raise
Sudo Biosciences is a biopharmaceutical company developing TYK2 pseudokinase inhibitors, including brain-penetrant CNS and topical dermatology candidates targeting MS, neuroinflammation, psoriasis, and autoimmune diseases.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
